Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
397.70
+3.50 (0.89%)
At close: Aug 10, 2026, 4:00 PM EDT
395.02
-2.68 (-0.67%)
After-hours: Aug 10, 2026, 4:33 PM EDT
Elevance Health Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 86,249 | 77,375 | 83,917 | 109,907 | 122,065 | 112,075 | |
Market Cap Growth | 38.63% | -7.80% | -23.65% | -9.96% | 8.91% | 42.23% |
Enterprise Value | 107,061 | 73,450 | 80,579 | 98,757 | 111,974 | 102,146 |
Last Close Price | 397.70 | 350.55 | 368.90 | 471.56 | 512.97 | 463.54 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 17.54 | 13.91 | 14.37 | 18.70 | 21.13 | 18.58 |
Forward PE | 14.55 | 13.09 | 11.25 | 13.17 | 16.14 | 16.70 |
PEG Ratio | 4.00 | 14.53 | 1.25 | 1.11 | 1.26 | 1.17 |
PS Ratio | 0.43 | 0.39 | 0.48 | 0.65 | 0.78 | 0.82 |
PB Ratio | 1.90 | 1.76 | 2.03 | 2.80 | 3.37 | 3.11 |
P/TBV Ratio | 15.80 | 18.15 | 91.01 | 30.13 | 80.61 | 94.00 |
P/FCF Ratio | 13.71 | 24.38 | 18.44 | 16.25 | 16.84 | 15.40 |
P/OCF Ratio | 11.56 | 18.04 | 14.45 | 13.63 | 14.53 | 13.40 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.53 | 0.37 | 0.46 | 0.58 | 0.72 | 0.75 |
EV/EBITDA Ratio | 16.18 | 8.83 | 9.13 | 10.96 | 12.18 | 12.13 |
EV/EBIT Ratio | 21.83 | 11.18 | 11.07 | 12.97 | 14.90 | 14.35 |
EV/FCF Ratio | 17.02 | 23.14 | 17.70 | 14.60 | 15.45 | 14.04 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.68 | 0.70 | 0.71 | 0.60 | 0.62 | 0.59 |
Debt / EBITDA Ratio | 4.69 | 3.85 | 3.54 | 2.79 | 2.62 | 2.74 |
Debt / FCF Ratio | 4.94 | 10.10 | 6.86 | 3.71 | 3.33 | 3.17 |
Net Debt / Equity Ratio | -0.14 | -0.09 | -0.08 | -0.29 | -0.28 | -0.28 |
Net Debt / EBITDA Ratio | -0.98 | -0.49 | -0.39 | -1.25 | -1.11 | -1.19 |
Net Debt / FCF Ratio | -1.03 | -1.28 | -0.76 | -1.66 | -1.40 | -1.37 |
Asset Turnover | 1.60 | 1.66 | 1.55 | 1.61 | 1.55 | 1.49 |
Quick Ratio | 1.38 | 1.41 | 1.32 | 1.30 | 1.27 | 1.33 |
Current Ratio | 1.52 | 1.54 | 1.45 | 1.44 | 1.40 | 1.47 |
Return on Equity (ROE) | 11.11% | 13.25% | 14.77% | 15.82% | 16.25% | 17.74% |
Return on Assets (ROA) | 3.34% | 4.65% | 4.87% | 5.59% | 5.82% | 5.95% |
Return on Invested Capital (ROIC) | 10.70% | 14.23% | 16.64% | 21.77% | 22.27% | 22.51% |
Return on Capital Employed (ROCE) | 6.03% | 8.38% | 10.15% | 11.70% | 11.96% | 11.89% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 5.75% | 7.19% | 6.96% | 5.35% | 4.73% | 5.38% |
FCF Yield | 7.29% | 4.10% | 5.42% | 6.16% | 5.94% | 6.49% |
Dividend Yield | 1.73% | 1.95% | 1.76% | 1.25% | 1.00% | 0.98% |
Payout Ratio | 30.61% | 27.00% | 25.22% | 23.30% | 20.85% | 17.93% |
Buyback Yield / Dilution | 3.64% | 3.56% | 1.90% | 2.22% | 1.62% | 2.95% |
Total Shareholder Return | 5.37% | 5.51% | 3.66% | 3.48% | 2.62% | 3.93% |